Novel JAK Inhibitor Improves QOL in Chronic Hand Eczema

TOPLINE: Treatment with delgocitinib cream, a topical pan-Janus kinase inhibitor, resulted in a significant improvement in health-related quality of life in patients with moderate to severe chronic hand eczema (CHE), with those receiving delgocitinib cream 20 mg/g showed greater improvements in quality-of-life measures than those receiving vehicle cream over 16 weeks…